Leukemia cure standard

Sufferers with early onset involving leukemia, in vivo you can find 1011 ~ 1012 / L (l) leukemia tissue, after treatment, leukemia cells could possibly be decreased to 109 ~ 1010 / L, these times the general clinical indicators had disappeared, hemogram, bone fragments marrow, as has been restored to normalcy, said for clinical remission with clinical remission, there are three several standards to judge their education of mitigation of leukemia treatment. (A) Mitigation Standard1. Comprehensive remission: (1) Bone marrow: The initial granulocyte (I-+ II-type) or an original single + young + younger single or pouring cream with the original cell count A 5%, red blood tissue and normal megakaryocyte mobile lines. Which M2b neutral with promyelocytic cell ratio inside normal range; M3-type from the original grain + promyelocytic I 5%; M4-type Zhongyuan grain-I + II + type + from the original single-child single-' 5%; M6-type Zhongyuan medication I Type + II-type I 5%, the original Crimson + Red, as very well as erythroid ratio associated with young normal; M7 medium-grained, reddish two-line ratio of standard, the former Giant along with young giant disappeared. (2) blood vessels as: hemoglobin (Hb) HA 100g (g) / L (men) or even ' 90g / L (women along with children), absolute neutrophils WI 1. 5xl09 / L, platelet matter ' 100xl09 / L, Zero category leukemia cells. (3) professional medical manifestations: No infiltration of leukemia attributable to the symptoms and symptoms, living normal or next to normal. 2. Partial remission: bone marrow Zhongyuan granulocyte-I + II-type (or the initial single + young + fresh single or pouring cream belonging to the original)> 5%, ' 20%, and also clinical, blood, as two haven't reached a standard connected with complete remission persons. THREE. Non-remission: bone marrow, blood and clinical for the reason that three failed to connect with the above standards. (B) relapseOne from the three with the adhering to recurrence: 1. In an original bone marrow granulocyte-I + II-type (or the first single + young + beginning single or pouring cream with the original)> 5%, ' 20%, after training of anti-leukemia therapy still can't reach clinical remission. ONLY TWO. Primitive bone marrow granulocyte-I + II-type (or the initial single + young + fresh single or pouring cream belonging to the original) "20% of people. 3. There extramedullary infiltration by way of leukemic cells. (C) constant complete remissionFrom treatment, was calculated on the date of clinical remission, during which no relapse about 3 ~ 5 years or higher commonly known. (D) Long-term survivalSince this date of diagnosis involving leukemia, the survival time (disease-free success or disease) for about 5 years as long-term success. In which disease-free tactical or leukemia-free survival period is defined through the clinical remission until relapse or even until the death of the state of clinical remission moment. (E) clinical cure Cessation regarding chemotherapy, disease-free survival of 5 years or A decade shall be known because clinical cure.